Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-16 4:45 pm Purchase | 2022-12-06 | 13G | NLS Pharmaceutics AG NLSP | BIOTECHNOLOGY VALUE FUND L P | 17,148 19.990% | 17,148 (New Position) | Filing History |
| 2022-02-24 06:06 am Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | Konofal Eric | 2,550 6.300% | 2,550 (New Position) | Filing History |
| 2022-02-18 5:30 pm Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | Magnetic Rock Investment AG | 8,138 20.000% | 8,138 (New Position) | Filing History |
| 2022-02-14 08:03 am Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | Zwyer Alexander | 3,000 7.400% | 3,000 (New Position) | Filing History |
| 2022-01-11 4:52 pm Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 4,015 9.990% | 666 (+19.89%) | Filing History |
| 2021-10-07 6:24 pm Purchase | 2021-10-07 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 3,349 9.990% | 3,349 (New Position) | Filing History |
| 2021-03-17 4:10 pm Sale | 2021-03-12 | 13G | NLS Pharmaceutics AG NLSP | Orin Hirschman | 1,443 4.900% | -857 (-37.26%) | Filing History |
| 2021-02-04 06:30 am Purchase | 2021-01-29 | 13G | NLS Pharmaceutics AG NLSP | Orin Hirschman | 2,300 7.800% | 2,300 (New Position) | Filing History |